Sanjiv.Parant.

{
  "main_header": {
    "sid": 328426,
    "name": "Sanjiv.Parant.",
    "stock_name": "Sanjiv.Parant.",
    "full_name": "Sanjivani Paranteral Ltd",
    "name_url": "stocks-analysis/sanjivparant",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "146.00",
    "chg": -9.7,
    "chgp": "-6.23%",
    "dir": -1,
    "prev_price": "155.70",
    "mcapval": "193.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531569,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE860D01013",
    "curr_date": "Mar 23",
    "curr_time": "",
    "bse_nse_vol": "21.84 k",
    "exc_status": "Active",
    "traded_date": "Mar 23, 2026",
    "traded_date_str": "2026 03 23",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sanjivparant-328426-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Sanjivani Paranteral Ltd Falls to 52-Week Low of Rs 145.6 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sanjivani-paranteral-ltd-stock-falls-to-52-week-low-of-rs1456-3908149",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SanjivaniParant_priceRelatedfactors_3908149.png",
        "date": "2026-03-23 14:11:40",
        "description": "For the third consecutive session, Sanjivani Paranteral Ltd has seen its share price decline, culminating in a fresh 52-week low of Rs 145.6 on 23 Mar 2026. This marks a significant 44.72% drop over the past year, far outpacing the broader Sensex's 4.97% decline during the same period."
      },
      {
        "title": "Sanjivani Paranteral Ltd Stock Hits 52-Week Low at Rs.146.3",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sanjivani-paranteral-ltd-stock-hits-52-week-low-at-rs1463-3898238",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SanjivaniParant_priceRelatedfactors_3898238.png",
        "date": "2026-03-18 09:50:18",
        "description": "Sanjivani Paranteral Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, recorded a new 52-week low of Rs.146.3 today, marking a significant decline in its stock price amid broader market movements and sectoral pressures."
      },
      {
        "title": "Sanjivani Paranteral Ltd Upgraded to Hold on Improved Valuation and Financial Metrics",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sanjivani-paranteral-ltd-upgraded-to-hold-on-improved-valuation-and-financial-metrics-3898013",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SanjivaniParant_mojoScore_3898013.png",
        "date": "2026-03-18 08:01:52",
        "description": "Sanjivani Paranteral Ltd has seen its investment rating upgraded from Sell to Hold, reflecting improved valuation metrics and robust financial trends despite recent share price weakness. The upgrade follows a comprehensive reassessment across quality, valuation, financial performance, and technical indicators, signalling a more balanced outlook for this micro-cap pharmaceutical player."
      },
      {
        "title": "Sanjivani Paranteral Ltd Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sanjivani-paranteral-ltd-valuation-shifts-signal-renewed-price-attractiveness-3897884",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SanjivaniParant_valuationdot_3897884.png",
        "date": "2026-03-18 08:00:20",
        "description": "Sanjivani Paranteral Ltd has seen a notable shift in its valuation parameters, moving from a fair to an attractive rating, driven primarily by changes in its price-to-earnings and price-to-book value ratios. Despite recent share price declines, the company’s valuation now presents a more compelling case relative to its historical averages and peer group, prompting a reassessment of its investment appeal within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Sanjivani Paranteral Ltd Stock Falls to 52-Week Low of Rs.153",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sanjivani-paranteral-ltd-stock-falls-to-52-week-low-of-rs153-3896526",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SanjivaniParant_priceRelatedfactors_3896526.png",
        "date": "2026-03-17 11:03:14",
        "description": "Sanjivani Paranteral Ltd’s shares declined sharply to a new 52-week low of Rs.153 on 17 Mar 2026, marking a significant downturn for the pharmaceuticals and biotechnology micro-cap. The stock has underperformed its sector and broader market indices amid a sustained negative trend over recent weeks."
      },
      {
        "title": "Sanjivani Paranteral Ltd Stock Falls to 52-Week Low of Rs.155",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sanjivani-paranteral-ltd-stock-falls-to-52-week-low-of-rs155-3890102",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SanjivaniParant_priceRelatedfactors_3890102.png",
        "date": "2026-03-13 19:24:20",
        "description": "Sanjivani Paranteral Ltd’s shares declined to a fresh 52-week low of Rs.155 on 13 Mar 2026, marking a significant downturn amid broader market weakness. The stock has now recorded a three-day consecutive fall, shedding 6.75% over this period, underlining persistent pressures within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Sanjivani Paranteral Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sanjivani-paranteral-ltd-is-rated-sell-3886557",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SanjivaniParant_mojoScore_3886557.png",
        "date": "2026-03-12 10:10:52",
        "description": "Sanjivani Paranteral Ltd is rated Sell by MarketsMOJO, with this rating last updated on 23 February 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock’s current position as of 12 March 2026, providing investors with the latest comprehensive analysis."
      },
      {
        "title": "Sanjivani Paranteral Ltd Valuation Shifts Signal Changing Market Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sanjivani-paranteral-ltd-valuation-shifts-signal-changing-market-sentiment-3872453",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SanjivaniParant_valuationdot_3872453.png",
        "date": "2026-03-05 08:00:27",
        "description": "Sanjivani Paranteral Ltd has experienced a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade as of late February 2026. This change reflects evolving market perceptions amid a challenging price performance, with the stock down 7.46% on the day and a year-to-date decline of 25.3%, contrasting with broader market gains. Investors are now reassessing the company’s price attractiveness relative to its historical averages and peer group within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Sanjivani Paranteral Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sanjivani-paranteral-ltd-is-rated-sell-3862010",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SanjivaniParant_mojoScore_3862010.png",
        "date": "2026-02-28 10:10:36",
        "description": "Sanjivani Paranteral Ltd is rated Sell by MarketsMOJO, with this rating last updated on 23 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 28 February 2026, providing investors with the latest insights into the company’s performance and outlook."
      }
    ],
    "total": 204,
    "sid": "328426",
    "stock_news_url": "https://www.marketsmojo.com/news/sanjivani-paranteral-328426"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "18-Feb-2026",
      "details": "Easnings call Transcript date 16th February 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "17-Feb-2026",
      "details": "Outcome of the Investors & Analysts for Q3 FY26 Results",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)",
      "datetime": "16-Feb-2026",
      "details": "Revised Press Relase for the Quarter ended 31st December 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Sanjivani Paranteral Ltd has declared <strong>5%</strong> dividend, ex-date: 19 Sep 25",
          "dt": "2025-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Sanjivani Paranteral Ltd Falls to 52-Week Low of Rs 145.6 as Sell-Off Deepens

2026-03-23 14:11:40

For the third consecutive session, Sanjivani Paranteral Ltd has seen its share price decline, culminating in a fresh 52-week low of Rs 145.6 on 23 Mar 2026. This marks a significant 44.72% drop over the past year, far outpacing the broader Sensex's 4.97% decline during the same period.

Read full news article

Sanjivani Paranteral Ltd Stock Hits 52-Week Low at Rs.146.3

2026-03-18 09:50:18

Sanjivani Paranteral Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, recorded a new 52-week low of Rs.146.3 today, marking a significant decline in its stock price amid broader market movements and sectoral pressures.

Read full news article

Sanjivani Paranteral Ltd Upgraded to Hold on Improved Valuation and Financial Metrics

2026-03-18 08:01:52

Sanjivani Paranteral Ltd has seen its investment rating upgraded from Sell to Hold, reflecting improved valuation metrics and robust financial trends despite recent share price weakness. The upgrade follows a comprehensive reassessment across quality, valuation, financial performance, and technical indicators, signalling a more balanced outlook for this micro-cap pharmaceutical player.

Read full news article

Sanjivani Paranteral Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-03-18 08:00:20

Sanjivani Paranteral Ltd has seen a notable shift in its valuation parameters, moving from a fair to an attractive rating, driven primarily by changes in its price-to-earnings and price-to-book value ratios. Despite recent share price declines, the company’s valuation now presents a more compelling case relative to its historical averages and peer group, prompting a reassessment of its investment appeal within the Pharmaceuticals & Biotechnology sector.

Read full news article

Sanjivani Paranteral Ltd Stock Falls to 52-Week Low of Rs.153

2026-03-17 11:03:14

Sanjivani Paranteral Ltd’s shares declined sharply to a new 52-week low of Rs.153 on 17 Mar 2026, marking a significant downturn for the pharmaceuticals and biotechnology micro-cap. The stock has underperformed its sector and broader market indices amid a sustained negative trend over recent weeks.

Read full news article

Sanjivani Paranteral Ltd Stock Falls to 52-Week Low of Rs.155

2026-03-13 19:24:20

Sanjivani Paranteral Ltd’s shares declined to a fresh 52-week low of Rs.155 on 13 Mar 2026, marking a significant downturn amid broader market weakness. The stock has now recorded a three-day consecutive fall, shedding 6.75% over this period, underlining persistent pressures within the Pharmaceuticals & Biotechnology sector.

Read full news article

Sanjivani Paranteral Ltd is Rated Sell

2026-03-12 10:10:52

Sanjivani Paranteral Ltd is rated Sell by MarketsMOJO, with this rating last updated on 23 February 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock’s current position as of 12 March 2026, providing investors with the latest comprehensive analysis.

Read full news article

Sanjivani Paranteral Ltd Valuation Shifts Signal Changing Market Sentiment

2026-03-05 08:00:27

Sanjivani Paranteral Ltd has experienced a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade as of late February 2026. This change reflects evolving market perceptions amid a challenging price performance, with the stock down 7.46% on the day and a year-to-date decline of 25.3%, contrasting with broader market gains. Investors are now reassessing the company’s price attractiveness relative to its historical averages and peer group within the Pharmaceuticals & Biotechnology sector.

Read full news article

Sanjivani Paranteral Ltd is Rated Sell

2026-02-28 10:10:36

Sanjivani Paranteral Ltd is rated Sell by MarketsMOJO, with this rating last updated on 23 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 28 February 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

View All News